Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-11

Clinical Trial Update: Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating ablation of perimitral flutter after atrial fibrillation ablation and its impact on patient outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Texas Cardiac Arrhythmia Research Foundation | Conditions: Atrial Fibrillation, Perimitral Flutter | Phase 3 | Status: COMPLETED